Investigation of the Systemic Immune Inflammation (SII) Index as an Indicator of Morbidity and Mortality in Type 2 Diabetic Retinopathy Patients in a 4-Year Follow-Up Period

被引:1
|
作者
Tabakoglu, Nilgun Tan [1 ]
Celik, Mehmet [2 ]
机构
[1] Trakya Univ, Fac Med Hosp, Hlth Res & Dev Ctr, TR-22100 Edirne, Turkiye
[2] Trakya Univ, Fac Med, Dept Endocrine & Metab Dis, TR-22100 Edirne, Turkiye
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 06期
关键词
systemic immune inflammation; diabetic retinopathy; type 2 diabetes mellitus; microvascular complications; macrovascular complications; CARDIOVASCULAR-DISEASE RISK; ASSOCIATION;
D O I
10.3390/medicina60060855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: This study aimed to investigate the relationship between the systemic immune inflammation (SII) index and the development of micro and macro complications and mortality within the first year and the following three years in type 2 diabetic retinopathy patients. Materials and Methods: The retrospective study included 523 type 2 diabetic retinopathy patients seen in the endocrinology outpatient clinic of our hospital between January and December 2019. Their demographic and clinical characteristics were analyzed using descriptive statistics. The normal distribution of quantitative data was assessed by the Shapiro-Wilk test. Mann-Whitney U, McNemar-Chi-square, and Cochran's Q tests were used to analyze the SII values and complication rates over time. An ROC analysis determined the sensitivity and specificity of SII. A multiple linear regression analysis examined the relationship between variables and SII, while Spearman's test assessed the correlation between CRP and SII. p < 0.05 was accepted as significant. Results: The mean age of patients was 63.5 +/- 9.3 years, with mean SII values of 821.4 +/- 1010.8. Higher SII values were significantly associated with acute-chronic renal failure, peripheral arterial disease, and hospitalization rates in both the first year and the following three years (p < 0.05 for all). Significant cut-off values for SII were found for micro- and macrovascular complications and death within the first year (p < 0.05 for all). The ROC curve analysis identified an optimal SII cut-off value of >594.0 for predicting near-term (1-year) complications and mortality, with a sensitivity of 73.8% and specificity of 49.4% (area under the ROC curve: 0.629, p = 0.001). Multiple linear regression indicated that smoking of at least 20 pack-years had a significant positive effect on SII. The Spearman test showed a weak positive correlation between SII and CRP. Conclusions: High SII values predict both early and late acute-chronic renal failure, peripheral arterial disease, and hospitalizations in patients with type 2 diabetic retinopathy. The study also shows that high SII values may predict microvascular and macrovascular complications of type 2 DM and mortality risk in the early period in patients with type 2 diabetic retinopathy. In addition, comorbidities and inflammatory habits, such as long-term smoking, should be considered in the clinical use of SII.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients
    Karlberg, Charlotte
    Falk, Christine
    Green, Anders
    Sjolie, Anne Katrin
    Grauslund, Jakob
    ACTA DIABETOLOGICA, 2012, 49 (04) : 263 - 268
  • [32] Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients
    Charlotte Karlberg
    Christine Falk
    Anders Green
    Anne Katrin Sjølie
    Jakob Grauslund
    Acta Diabetologica, 2012, 49 : 263 - 268
  • [33] Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes:: a 4-year follow-up
    Alvarsson, M.
    Sundkvist, G.
    Lager, I.
    Berntorp, K.
    Fernqvist-Forbes, E.
    Steen, L.
    Orn, T.
    Holberg, M. A.
    Kirksaether, N.
    Grill, V.
    DIABETES OBESITY & METABOLISM, 2008, 10 (05): : 421 - 429
  • [34] Lipoprotein (a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: A 9-year follow-up study
    Hernandez, C
    Francisco, G
    Chacon, P
    Mesa, J
    Simo, R
    DIABETES, 2003, 52 : A155 - A155
  • [35] Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients -: A 10-year follow-up study
    Hernández, C
    Francisco, G
    Chacón, P
    Simó, R
    DIABETES CARE, 2005, 28 (04) : 931 - 933
  • [36] Long-Term Safety and Efficacy of Saxagliptin after 4-Year Follow-Up of Patients with Type 2 Diabetes
    Rosenstock, Julio
    Luiz Gross, Jorge
    Aguilar Salinas, Carlos A.
    Hissa, Miguel
    Berglind, Niklas
    Ravichandran, Shoba
    Fleming, Douglas
    DIABETES, 2011, 60 : A298 - A298
  • [37] Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study
    Russo, Giuseppina T.
    Giorda, Carlo B.
    Cercone, Stefania
    De Cosmo, Salvatore
    Nicolucci, Antonio
    Cucinotta, Domenico
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (06)
  • [38] Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
    Van de Laar, FA
    Van de Lisdonk, EH
    Lucassen, PLBJ
    Tigchelaar, JMH
    Meyboom, S
    Mulder, J
    van den Hoogen, HJM
    Rutten, GEHM
    van Weel, C
    BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (500): : 177 - 182
  • [39] Treatment gaps and mortality among patients with familial hypercholesterolemia and cardiovascular disease: a 4-year follow-up study
    Shemesh, Elad
    Azaiza, Ameer
    Zafrir, Barak
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) : E21 - E22
  • [40] Association of the systemic immune-inflammation index (SII) and severity of diabetic ketoacidosis in patients with type 1 diabetes mellitus: a retrospective cohort study
    Aon, Mohamed
    Aoun, Ahmed H.
    Alshami, Ahmad
    Alharbi, Abdulrahman
    Alshammari, Fahed
    Alnajjar, Mohamad
    Almutawtah, Ahmad
    Bin Naji, Bader
    Alsaeed, Abdullateef
    Abdelwahab, Omar A.
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (07): : 3865 - 3872